Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients
Clinical trial NCT00203164 · COMPLETED
Trial details
- NCT number
- NCT00203164
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-05-01
- Primary completion
- 2005-07-01
- Enrollment
- 254
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.